[go: up one dir, main page]

GB0702457D0 - New combination 666 - Google Patents

New combination 666

Info

Publication number
GB0702457D0
GB0702457D0 GB0702457A GB0702457A GB0702457D0 GB 0702457 D0 GB0702457 D0 GB 0702457D0 GB 0702457 A GB0702457 A GB 0702457A GB 0702457 A GB0702457 A GB 0702457A GB 0702457 D0 GB0702457 D0 GB 0702457D0
Authority
GB
United Kingdom
Prior art keywords
new combination
new
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0702457A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0702457A priority Critical patent/GB0702457D0/en
Publication of GB0702457D0 publication Critical patent/GB0702457D0/en
Priority to PCT/GB2008/000396 priority patent/WO2008096121A1/en
Ceased legal-status Critical Current

Links

GB0702457A 2007-02-08 2007-02-08 New combination 666 Ceased GB0702457D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0702457A GB0702457D0 (en) 2007-02-08 2007-02-08 New combination 666
PCT/GB2008/000396 WO2008096121A1 (en) 2007-02-08 2008-02-06 Combinations of beta-2-adrenoceptor agonistic benzothiazolone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0702457A GB0702457D0 (en) 2007-02-08 2007-02-08 New combination 666

Publications (1)

Publication Number Publication Date
GB0702457D0 true GB0702457D0 (en) 2007-03-21

Family

ID=37898977

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0702457A Ceased GB0702457D0 (en) 2007-02-08 2007-02-08 New combination 666

Country Status (2)

Country Link
GB (1) GB0702457D0 (en)
WO (1) WO2008096121A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
EP2100599A1 (en) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
BRPI0822693A2 (en) 2008-05-13 2015-07-07 Astrazeneca Ab Quinuclidine derivatives as m3 muscarinic receptor antagonists
KR20110010725A (en) * 2008-05-13 2011-02-07 아스트라제네카 아베 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST
CA2726746A1 (en) 2008-06-18 2009-12-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
UY31920A (en) * 2008-06-20 2010-01-29 Astrazeneca Ab NEW COMBINATION-408
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
EP3646870A1 (en) 2009-07-22 2020-05-06 Puretech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
EP3856182B1 (en) 2018-09-28 2025-12-24 Karuna Therapeutics, Inc. Compositions and methods for treating disorders ameliorated by muscarnic receptor activation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200738658A (en) * 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
WO2008096121A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
GB0702457D0 (en) New combination 666
GB0703999D0 (en) New combination 667
GB0711078D0 (en) Combination 500
GB0711402D0 (en) Combination 501
GB0700177D0 (en) Mintop 1
AU316643S (en) Bed - SE 2
GB0717636D0 (en) Shock-stopper 2
GB0717640D0 (en) Hydrodechlorification 2
GB0717641D0 (en) Hydrodechlorification 3
GB0723129D0 (en) Plug-shield 3
GB0723178D0 (en) 3 EasyHead
GB0717753D0 (en) Footsies 100%
GB0714687D0 (en) Note 005
GB0714675D0 (en) Note 014
GB0714672D0 (en) Note 011
GB0714690D0 (en) Note 008
GB0714673D0 (en) Note 012
GB0714692D0 (en) Note 010
GB0714689D0 (en) Note 007
GB0714684D0 (en) Note 002
GB0714683D0 (en) Note 001
GB0714688D0 (en) Note 006
GB0714691D0 (en) Note 009
GB0714686D0 (en) Note 004
GB0714674D0 (en) Note 013

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)